{
"id":"mk19_a_nr_s9",
"subspecialtyId":"nr",
"title":"Neuromuscular Disorders",
"jsonContent":{
"type":"section",
"id":"mk19_a_nr_s9",
"title":{
"__html":"Neuromuscular Disorders"
},
"titleNode":{
"type":"section-title",
"hlId":"33be05",
"children":[
"Neuromuscular Disorders"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_nr_s9_1",
"title":{
"__html":"Overview"
},
"titleNode":{
"type":"section-title",
"hlId":"3b8782",
"children":[
"Overview"
]
},
"children":[
{
"type":"p",
"hlId":"29d3b2",
"children":[
"Peripheral and central nervous system disorders can be differentiated on the basis of history and neurologic examination findings ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t44",
"wrapId":"1",
"children":[
"Table 44"
]
}
]
},
")"
]
},
". Neuromuscular disorders include myopathies, neuromuscular junction disorders, peripheral neuropathies, plexopathies, radiculopathies, and motor neuron diseases ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t45",
"wrapId":"1",
"children":[
"Table 45"
]
}
]
}
]
},
" and ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t46",
"wrapId":"1",
"children":[
"Table 46"
]
}
]
},
")"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_a_nr_t44",
"mk19_a_nr_t45",
"mk19_a_nr_t46"
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_2",
"title":{
"__html":"Peripheral Neuropathies"
},
"titleNode":{
"type":"section-title",
"hlId":"161956",
"children":[
"Peripheral Neuropathies"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_nr_s9_2_1",
"title":{
"__html":"Classification, Findings, and Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"8d6c7f",
"children":[
"Classification, Findings, and Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"c0c355",
"children":[
"Symptoms of peripheral neuropathy include negative (sensory loss) or positive (paresthesia, dysesthesia, and pain) sensory symptoms, weakness, or autonomic dysfunction. Neuropathies are classified on the basis of distribution of sensorimotor deficits (symmetric versus asymmetric, distal versus proximal, focal versus generalized), pathology (demyelinating versus axonal), family history, and autonomic involvement ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_nr_f30",
"wrapId":"2",
"children":[
"Figure 30"
]
}
]
},
")"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_a_nr_f30"
]
},
{
"type":"p",
"hlId":"d88a77",
"children":[
"For all patients with a suspected peripheral neuropathy, a complete blood count, an erythrocyte sedimentation rate determination, serum protein electrophoresis with immune fixation, thyroid function tests, hemoglobin A",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1c"
]
},
"/fasting plasma glucose determination, and vitamin B",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"12"
]
},
" measurement are necessary. In specific clinical settings, additional tests, including CSF analysis, genetic testing, and other specialized laboratory testing, can help clarify the diagnosis ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t47",
"wrapId":"3",
"children":[
"Table 47"
]
}
]
},
")"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"3",
"contentIds":[
"mk19_a_nr_t47"
]
},
{
"type":"p",
"hlId":"f3f3b8",
"children":[
"Electromyography (EMG), including both nerve conduction studies and needle electrode examination (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"video-link",
"target":"mk19_a_nr_v15",
"wrapId":"4",
"children":[
"Video 15"
]
}
]
},
"), can differentiate neuropathy from other neuromuscular disorders. In neuropathy, motor unit potentials are high amplitude and prolonged, whereas in myopathy, these potentials are low amplitude and brief. If neuropathy is present, EMG also can determine whether it is demyelinating or axonal. In demyelinating neuropathies, velocity of nerve conduction decreases, but in axonopathy, velocity remains unchanged. The presence of weakness, asymmetry, proximal findings, rapid course, or atypical features should prompt EMG testing. In patients with a slowly progressive distal symmetric sensory neuropathy with negative family history, however, EMG may not be required."
]
},
{
"type":"inline-wrap",
"wrapId":"4",
"contentIds":[
"mk19_a_nr_v15"
]
},
{
"type":"p",
"hlId":"ebed53",
"children":[
"Nerve biopsy should only be considered in rare settings in which concern for a vasculitic, infectious, or infiltrative neuropathy exists. Autonomic tests, including quantitative sudomotor axon reflex and tilt table tests, can help confirm autonomic neuropathy but are rarely performed in practice."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"ed37b7",
"hvc":true,
"children":[
"Electromyography (EMG) can differentiate neuropathy from other neuromuscular disorders, and if neuropathy is present, EMG can determine whether it is axonal or demyelinating."
]
},
{
"type":"keypoint",
"hlId":"4a5ade",
"children":[
"The presence of weakness, asymmetry, proximal findings, a rapid course, or atypical features should prompt testing with electromyography in a patient with a suspected peripheral neuropathy."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_2_2",
"title":{
"__html":"Mononeuropathies"
},
"titleNode":{
"type":"section-title",
"hlId":"03d7ca",
"children":[
"Mononeuropathies"
]
},
"children":[
{
"type":"p",
"hlId":"f63e11",
"children":[
"Mononeuropathies involve a single nerve and can cause both motor and sensory symptoms within the territory of the affected nerve. Sequential involvement of multiple nerves may be seen in mononeuropathy multiplex, a condition most often associated with pain and caused by vasculitis. Plexopathies originate at the level of the brachial or lumbosacral plexus and involve multiple sensory and motor nerves simultaneously."
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_2_2_1",
"title":{
"__html":"Carpal Tunnel Syndrome"
},
"titleNode":{
"type":"section-title",
"hlId":"dd3528",
"children":[
"Carpal Tunnel Syndrome"
]
},
"children":[
{
"type":"p",
"hlId":"7ee641",
"children":[
"Carpal tunnel syndrome results from focal compression of the median nerve at the wrist. Most often, paresthesia and pain are experienced in the first three digits but may radiate to the entire hand or proximally. With milder symptoms, diagnosis of carpal tunnel syndrome can be made clinically, and treatment is supportive, including neutral positioning, wrist splints, and pain control. The presence of weakness, thenar atrophy, refractory pain, or active denervation evident on EMG should prompt surgical decompression. See ",
{
"type":"cross-reference",
"target":"mk19_a_gm_s7_4_4_1",
"children":[
"MKSAP 19 General Internal Medicine 1"
]
},
" for further information about carpal tunnel syndrome."
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_2_2_2",
"title":{
"__html":"Ulnar, Radial, and Peroneal Mononeuropathies"
},
"titleNode":{
"type":"section-title",
"hlId":"77767f",
"children":[
"Ulnar, Radial, and Peroneal Mononeuropathies"
]
},
"children":[
{
"type":"p",
"hlId":"a22183",
"children":[
"Ulnar mononeuropathy presents with paresthesia and numbness in digits 4 and 5, and in severe cases with weakness and atrophy of intrinsic hand muscles. Site of compression is commonly at the medial epicondyle because of frequent leaning on the elbow. Management includes education to avoid pressure on the nerve, elbow splinting, and, in patients with persistent pain and progressive weakness, decompression surgery."
]
},
{
"type":"p",
"hlId":"0f93f2",
"children":[
"Radial mononeuropathy presents as wrist drop and finger extensor weakness caused by compression of the nerve near the axilla as it crosses the humerus. This is often caused by prolonged immobility in comatose or intoxicated patients (“Saturday night palsy”); spontaneous recovery is typical."
]
},
{
"type":"p",
"hlId":"683a25",
"children":[
"Peroneal nerve palsy presents as foot drop and is caused by compression of the nerve at the head of the fibula, which usually results from crossing of the legs, immobility, or trauma. Patients who do not improve within 3 months should be further assessed by EMG and lumbosacral imaging because proximal lesions may mimic peroneal palsy."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"a040d5",
"hvc":true,
"children":[
"In patients with carpal tunnel syndrome the presence of weakness, thenar atrophy, refractory pain, or active denervation evident on electromyography should prompt decompression surgery."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_2_2_3",
"title":{
"__html":"Bell Palsy"
},
"titleNode":{
"type":"section-title",
"hlId":"c2acfb",
"children":[
"Bell Palsy"
]
},
"children":[
{
"type":"p",
"hlId":"90ca7f",
"children":[
"Bell palsy is idiopathic paralysis of the facial nerve (cranial nerve VII) that leads to unilateral paralysis of upper and lower facial muscles. In contrast, upper facial muscles are spared in central facial weakness (stroke) because of their bilateral innervation. Periauricular pain, altered taste, and hyperacusis also may occur. Between 70% and 90% of patients with Bell palsy fully recover within a few weeks. In classic Bell palsy, brain imaging and laboratory testing are not required. Treatment with a 10-day course of oral prednisone, started within 72 hours of onset, is recommended to expedite both the rate and speed of full recovery. The utility of adding antiviral treatment to prednisone is controversial, but there may be a small benefit to adding antiviral treatment in patients with severe palsy. Use of an eye patch and artificial tears to prevent corneal dryness is recommended. Synkinesis (concomitant movement of perioral and periorbital muscles) may result from aberrant reinnervation after Bell palsy."
]
},
{
"type":"p",
"hlId":"292c41",
"children":[
"Secondary causes for facial nerve palsy include diabetes mellitus, Lyme disease, sarcoidosis, HIV, vasculitis, and malignancy. If a secondary cause is suspected on the basis of history (subacute onset over days, comorbidities, rash) or clinical examination (deficits unrelated to the facial nerve such as weakness in extraocular, masticatory, or lingual muscles), additional testing is indicated, and prednisone is typically avoided. Brain MRI with contrast also is recommended in patients with lingering or worsening weakness after 2 months."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"a0cd02",
"hvc":true,
"children":[
"In classic Bell palsy, brain imaging and laboratory testing is not required; treatment with a 10-day course of oral prednisone, started within 72 hours of onset, may expedite both the rate and speed of full recovery."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_2_2_4",
"title":{
"__html":"Brachial and Lumbosacral Plexopathies"
},
"titleNode":{
"type":"section-title",
"hlId":"2de114",
"children":[
"Brachial and Lumbosacral Plexopathies"
]
},
"children":[
{
"type":"p",
"hlId":"41e7f4",
"children":[
"Common causes of brachial and lumbosacral plexopathy include diabetes, malignancy, radiation, and trauma. Imaging is mandatory to rule out structural lesions and malignancy. Idiopathic brachial plexitis (also known as neuralgic amyotrophy) presents with subacute severe scapular pain followed by pronounced weakness and atrophy in shoulder-girdle and upper extremity muscles. It is likely immune mediated, and a triggering event, such as infection or surgery, usually precedes this presentation, although the infection or surgery is not in the region of the brachial plexus. EMG can confirm the diagnosis, and imaging can rule out alternative causes. Treatment is supportive. Gradual recovery (90% by 3 years) is common. Idiopathic lumbosacral radiculoplexus neuropathy is immune mediated and very similar in presentation to diabetic amyotrophy. (See ",
{
"type":"cross-reference",
"target":"mk19_a_nr_s9_2_3_1",
"children":[
"Neuropathies of Diabetes Mellitus and Impaired Glucose Tolerance"
]
},
".)"
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_2_3",
"title":{
"__html":"Polyneuropathies"
},
"titleNode":{
"type":"section-title",
"hlId":"07816b",
"children":[
"Polyneuropathies"
]
},
"children":[
{
"type":"p",
"hlId":"a0139b",
"children":[
"Polyneuropathies arise from various disorders causing injury to peripheral nerves (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t47",
"wrapId":"5",
"children":[
"Table 47"
]
}
]
},
")"
]
},
". Polyneuropathies may affect either large nerve fibers (and lead to impaired proprioception, hyporeflexia, and weakness) or small nerve fibers (and cause pain, dysesthesia, and dysautonomia). Additionally, they may be primarily axonal or demyelinating. If axonal, the distal axonal segments are affected first, which leads to a length-dependent stocking-glove pattern of involvement. A sensory-predominant distal symmetric neuropathy is typically seen with metabolic, toxic, and systemic neuropathies. Demyelinating neuropathies, which result from injury to the myelin sheath of the peripheral nerve, can cause non–length-dependent weakness and sensory loss."
]
},
{
"type":"inline-wrap",
"wrapId":"5",
"contentIds":[
"mk19_a_nr_t47"
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_2_3_1",
"title":{
"__html":"Neuropathies of Diabetes Mellitus and Impaired Glucose Tolerance"
},
"titleNode":{
"type":"section-title",
"hlId":"1b8434",
"children":[
"Neuropathies of Diabetes Mellitus and Impaired Glucose Tolerance"
]
},
"children":[
{
"type":"p",
"hlId":"365e0c",
"children":[
"Diabetes mellitus causes various types of neuropathy ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t48",
"wrapId":"6",
"children":[
"Table 48"
]
}
]
},
")"
]
},
". The most common presentation is symmetric distal neuropathy involving small and large sensory fibers and, to a lesser extent, distal motor nerves. Clinical examination may reveal length-dependent loss of light touch, pinprick and vibration sensations, loss of the ankle reflex, and—in advanced disease—distal weakness. Pain and paresthesia may predominate, especially when small fibers are involved. Patients with a pure small-fiber variant of symmetric distal neuropathy may have normal distal sensory and reflex findings on examination and normal results on EMG at presentation; this pattern also can be seen even in patients with impaired glucose tolerance. Between 11% and 25% of patients with glucose intolerance have evidence of small-fiber neuropathy on specialized testing, but only a minority (5%-10%) are symptomatic."
]
},
{
"type":"inline-wrap",
"wrapId":"6",
"contentIds":[
"mk19_a_nr_t48"
]
},
{
"type":"p",
"hlId":"fb6107",
"children":[
"Autonomic diabetic neuropathy can cause orthostatic hypotension, erectile dysfunction, abnormal hidrosis, and gastroparesis. Dysautonomia also can mask symptoms of hypoglycemia and may predispose patients to silent myocardial infarction. Diabetic mononeuropathy can involve the cranial nerves (especially III, VI, and VII) and truncal nerve roots (with a dermatomal pattern of pain and paresthesia in the chest or abdomen) and predispose patients to entrapment neuropathies, such as carpal tunnel syndrome."
]
},
{
"type":"p",
"hlId":"b17943",
"children":[
"Diabetic amyotrophy, also known as proximal lumbosacral radiculoneuropathy, is associated with subacute painful involvement of the lumbosacral plexus followed by resolution of pain and onset of marked asymmetric weakness with atrophy and weight loss. Spontaneous recovery over 1 to 3 years is typical but may be incomplete."
]
},
{
"type":"p",
"hlId":"4e8622",
"children":[
"Tight glycemic control, exercise, and management of dyslipidemia, obesity, and metabolic syndrome can slow the progression and improve the symptoms of diabetic polyneuropathy. Management of diabetic amyotrophy consists of supportive measures, physical therapy, and pain control but does not involve immunosuppression. See ",
{
"type":"cross-reference",
"target":"mk19_b_en_s1_5_4",
"children":[
"MKSAP 19 Endocrinology and Metabolism"
]
},
" for further information about diabetic neuropathy, including neuropathic pain treatment."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"58a27e",
"children":[
"The most common form of neuropathy secondary to diabetes is a symmetric distal neuropathy involving small and large sensory fibers and, to less extent, distal motor nerves; examination may reveal length-dependent loss of light touch, pinprick and vibration sensations, loss of the ankle reflex, and—in advanced disease—distal weakness."
]
},
{
"type":"keypoint",
"hlId":"3b4669",
"children":[
"Tight glycemic control, exercise, and management of dyslipidemia, obesity, and metabolic syndrome can slow the progression and improve the symptoms of diabetic polyneuropathy."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_2_3_2",
"title":{
"__html":"Hereditary Neuropathies"
},
"titleNode":{
"type":"section-title",
"hlId":"76447a",
"children":[
"Hereditary Neuropathies"
]
},
"children":[
{
"type":"p",
"hlId":"b9175d",
"children":[
"Charcot-Marie-Tooth disease consists of more than 70 genetic disorders in which peripheral neuropathy is the only or main clinical manifestation. The most common inherited neuropathy, Charcot-Marie-Tooth disease type 1 is an autosomal dominant demyelinating neuropathy presenting with early onset, slowly progressive distal weakness, areflexia, and sensory loss without pain or paresthesia. Foot deformities, such as hammer toes, high arches, and distal leg atrophy, are common ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_nr_f31",
"wrapId":"7",
"children":[
"Figure 31"
]
}
]
},
")"
]
},
". EMG typically reveals a uniform slowing of nerve conduction velocities, and genetic testing is confirmatory."
]
},
{
"type":"inline-wrap",
"wrapId":"7",
"contentIds":[
"mk19_a_nr_f31"
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_2_3_3",
"title":{
"__html":"Inflammatory Polyradiculoneuropathies"
},
"titleNode":{
"type":"section-title",
"hlId":"fca004",
"children":[
"Inflammatory Polyradiculoneuropathies"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_nr_s9_2_3_3_1",
"title":{
"__html":"Guillain-Barré Syndrome"
},
"titleNode":{
"type":"section-title",
"hlId":"d173a9",
"children":[
"Guillain-Barré Syndrome"
]
},
"children":[
{
"type":"p",
"hlId":"6f69c3",
"children":[
"Guillain-Barré syndrome (GBS) is an acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness. Onset is often preceded by a respiratory or gastrointestinal infection, triggering a T-cell–mediated autoimmune attack against peripheral nerve and root myelin. Weakness is ascending, starting in the lower extremities, spreading to the upper limbs and bulbar and respiratory muscles, and reaching its nadir in less than 4 weeks. The weakness may occur first in the proximal muscles. Paresthesia and early low back pain are common. Dysautonomia can be severe and predispose patients to labile blood pressure and arrhythmias. Progressive respiratory and bulbar weakness may lead to rapid respiratory failure. On examination, diffuse areflexia is a key finding; there is not marked sensory loss, even in the setting of paresthesia. Miller-Fisher variant of GBS presents with ataxia, ophthalmoplegia and antibodies to GQ1b ganglioside protein."
]
},
{
"type":"p",
"hlId":"8e80fc",
"children":[
"The differential diagnosis of GBS includes botulism (descending weakness), myasthenic crisis (without pain and paresthesia), acute myelopathies (hyperreflexia and upper motor neuron signs), West Nile virus infection (asymmetric paralysis, fever, and muscle pain), carcinomatous and sarcoid meningitis (slower course), Lyme disease, HIV seroconversion, porphyria, and tick paralysis."
]
},
{
"type":"p",
"hlId":"08b8a6",
"children":[
"CSF analysis shows a pattern of a highly elevated protein level with a normal or mildly elevated leukocyte count (albuminocytologic dissociation) in 90% of patients. Early normal CSF does not rule out GBS. EMG is the confirmatory test and shows a predominantly demyelinating pattern; sensitivity is initially low but 90% by week 5. Initiation of treatment should not await EMG confirmation; a negative early study should be repeated later if the diagnosis remains suspected. Additional studies, such as spinal MRI and serologic testing for Lyme disease, HIV, and myasthenia antibodies, may be considered in appropriate clinical settings."
]
},
{
"type":"p",
"hlId":"bd44c8",
"children":[
"Therapy includes supportive management and immunotherapy. All patients with GBS should be hospitalized for close respiratory and cardiovascular monitoring. Decisions about intubation, which should be guided by the need for airway protection and measurement of forced vital capacity and negative inspiratory force, should be made before emergence of hypoxemia. Both plasmapheresis and intravenous immune globulin (IVIG) have equal efficacy in shortening the time to recovery and the duration of ventilation. Serial treatment with IVIG after plasma exchange is not superior to either treatment alone and has not shown significant added benefit. Glucocorticoids are contraindicated in GBS and may worsen outcome. Prognosis is favorable, with 80% of patients resuming ambulation by 6 months after onset. Relapse occurs in 6% of patients with GBS and requires repeated treatment."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"cc9806",
"children":[
"Guillain-Barré syndrome is an acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive ascending flaccid weakness."
]
},
{
"type":"keypoint",
"hlId":"d10993",
"children":[
"All patients with Guillain-Barré syndrome should be hospitalized for close respiratory and cardiovascular monitoring; plasmapheresis and intravenous immune globulin have equal efficacy in shortening the time to recovery and the duration of ventilation."
]
},
{
"type":"keypoint",
"hlId":"afee06",
"children":[
"Glucocorticoids are contraindicated in Guillain-Barré syndrome and may worsen outcome."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_2_3_3_2",
"title":{
"__html":"Chronic Inflammatory Demyelinating Polyradiculoneuropathy"
},
"titleNode":{
"type":"section-title",
"hlId":"e622cd",
"children":[
"Chronic Inflammatory Demyelinating Polyradiculoneuropathy"
]
},
"children":[
{
"type":"p",
"hlId":"f8735a",
"children":[
"Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a potentially treatable autoimmune neuropathy. CIDP often presents with a progressive or relapsing symmetric proximal and distal weakness and sensory symptoms with diffuse areflexia. Its temporal course is often subacute with progression after 8 weeks of onset. Atypical forms include multifocal asymmetric and distal symmetric variants, but respiratory failure is rare. CIDP may be isolated or occur in the setting of several other systemic conditions, including diabetes mellitus, lymphoma, and HIV. CSF findings are like those of GBS, and a demyelinating pattern on EMG is the key to diagnosis. Nerve biopsy is often unnecessary but, in complex presentations, can differentiate CIDP from vasculitis or amyloidosis. First-line treatments include glucocorticoids, periodic IVIG, or plasma exchange, which all have similar efficacy. Treatment is typically continued for at least 6 months. Half of patients achieve remission, but the other half relapse and require resumption of immunotherapy. Second-line therapies, including azathioprine, mycophenolate mofetil, cyclosporine, or cyclophosphamide, are often used off-label to treat refractory disease. Subcutaneous immunoglobin therapy is available for prevention of relapse in CIDP."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_2_3_4",
"title":{
"__html":"Critical Illness Neuropathy"
},
"titleNode":{
"type":"section-title",
"hlId":"965388",
"children":[
"Critical Illness Neuropathy"
]
},
"children":[
{
"type":"p",
"hlId":"7dd3f3",
"children":[
"Prolonged intensive care treatment, particularly in association with sepsis and multiorgan failure, can lead to diffuse weakness, an inability to wean patients from ventilators, and prolonged posthospitalization weakness. Weakness may be secondary to critical illness myopathy, critical illness axonal neuropathy, or a combination of the two. Critical illness myopathy is more common, less severe, and potentially caused by channelopathy (a disease involving dysfunction of a cellular ion channel) triggered by sepsis and systemic disease. Critical illness neuropathy, on the other hand, is associated with microcirculatory axonal damage and a more protracted recovery. EMG can differentiate between the two, but often components of both are simultaneously present. Differential diagnosis includes GBS, myasthenia gravis, vasculitis, and central weakness. No definitive treatment is available, but appropriate glycemic control, early mobilization and therapy, and minimizing glucocorticoid use improve prognosis."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"7c1e9b",
"children":[
"Critical illness axonal polyneuropathy often coexists with critical illness myopathy and can lead to diffuse weakness, an inability to wean patients from ventilators, and prolonged posthospitalization weakness."
]
},
{
"type":"keypoint",
"hlId":"c80984",
"children":[
"No definitive treatment is available for critical illness neuropathy, but appropriate glycemic control, early mobilization and therapy, and minimizing glucocorticoid use improve prognosis."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_2_3_5",
"title":{
"__html":"Paraproteinemic Neuropathy"
},
"titleNode":{
"type":"section-title",
"hlId":"e4de4b",
"children":[
"Paraproteinemic Neuropathy"
]
},
"children":[
{
"type":"p",
"hlId":"597e7a",
"children":[
"Paraproteinemic neuropathy frequently presents as a symmetric distal sensory neuropathy, but sensorimotor, multifocal motor, or cranial nerve variants also are possible. Therefore, all patients with peripheral neuropathy should be screened for paraproteinemia. Neuropathies associated with monoclonal proteins occur in monoclonal gammopathy of undetermined significance, multiple myeloma, amyloidosis, and other hematologic malignancies. (See ",
{
"type":"cross-reference",
"target":"mk19_b_hm_s3_5",
"children":[
"MKSAP 19 Hematology."
]
},
") Diagnosis depends on the detection of monoclonal proteins, and treatment is based on the underlying condition. A CIDP-like severe polyneuropathy may occur in paraproteinemic neuropathy in association with organomegaly, endocrinopathy, monoclonal plasma cell disorder, and skin changes (POEMS syndrome); this syndrome always is associated with λ paraproteinemia. Treatment is similar to that of multiple myeloma and may reverse neuropathic symptoms."
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_2_3_6",
"title":{
"__html":"Autonomic Neuropathy"
},
"titleNode":{
"type":"section-title",
"hlId":"993763",
"children":[
"Autonomic Neuropathy"
]
},
"children":[
{
"type":"p",
"hlId":"19a14b",
"children":[
"Autonomic neuropathies manifest as diffuse or focal impairment of cholinergic or sympathetic autonomic systems. Whereas diabetes, amyloidosis, and HIV are common disorders underlying secondary autonomic neuropathy, primary autoimmune ganglionopathy is an important and potentially treatable cause of autonomic neuropathy that is often associated with antibodies against ganglionic nicotinic acetylcholine receptors. The presentation may range from acute pandysautonomia to chronic focal autonomic dysfunction. Antibody testing and skin biopsy help with diagnosis. Response to IVIG, plasmapheresis, or immunosuppression is common."
]
},
{
"type":"p",
"hlId":"2911d5",
"children":[
"Amyloid neuropathy is caused by extracellular deposition of amyloid protein in peripheral nerves and other tissues. Amyloidosis starts with painful small-fiber neuropathy and progressively causes major autonomic impairment and weakness and multiorgan involvement. Bilateral carpal tunnel syndrome can be seen."
]
},
{
"type":"p",
"hlId":"7b2545",
"children":[
"Primary amyloidosis is associated with monoclonal proteins, whereas familial amyloidosis is secondary to transthyretin gene mutation (see ",
{
"type":"cross-reference",
"target":"mk19_b_hm_s3_5",
"children":[
"MKSAP 19 Hematology"
]
},
"). Patisiran, a small interfering ribonucleic acid, and inotersen, an antisense oligonucleotide, are FDA approved treatments hereditary transthyretin-related neuropathy."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_3",
"title":{
"__html":"Amyotrophic Lateral Sclerosis"
},
"titleNode":{
"type":"section-title",
"hlId":"0d5f6d",
"children":[
"Amyotrophic Lateral Sclerosis"
]
},
"children":[
{
"type":"p",
"hlId":"669259",
"children":[
"Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease of motor neurons that causes progressive weakness, atrophy, and early death. This motor neuron disease often begins as isolated extremity or bulbar weakness (dysphagia, dysarthria [see ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"video-link",
"target":"mk19_a_nr_v02",
"wrapId":"8",
"children":[
"Video 2"
]
}
]
},
"]) but relentlessly spreads to other regions. Upper (hyperreflexia, spasticity, and extensor plantar response [see ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"video-link",
"target":"mk19_a_nr_v14",
"wrapId":"8",
"children":[
"Video 14"
]
}
]
},
"]) and lower (atrophy and fasciculation [see ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"video-link",
"target":"mk19_a_nr_v06",
"wrapId":"8",
"children":[
"Video 6"
]
}
]
},
"]) motor neuron signs and the absence of sensory deficits are characteristic. Frontotemporal dementia occurs in 20% of affected patients, but oculomotor palsy, incontinence, and tremor are atypical. Diagnosis is based on clinical evidence of both upper and lower motor neuron signs on examination and EMG evidence of lower motor neuron signs in at least two (probable ALS) or more (definite ALS) regions. Alternative diagnoses also must be excluded by brain and cervical spinal imaging and laboratory testing; cervical cord compression, vitamin B",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"12"
]
},
" and copper deficiencies, Lyme disease, hyperparathyroidism, and thyrotoxicosis must be excluded. Multifocal motor neuropathy is a treatable ALS mimic characterized by severe weakness with minimal atrophy, absence of upper motor neuron signs, and EMG evidence of motor conduction block."
]
},
{
"type":"inline-wrap",
"wrapId":"8",
"contentIds":[
"mk19_a_nr_v02",
"mk19_a_nr_v14",
"mk19_a_nr_v06"
]
},
{
"type":"p",
"hlId":"b03baa",
"children":[
"Treatment of ALS is supportive and should involve multidisciplinary care. Riluzole, a glutamate release blocker, and edaravone, a free radical scavenger, are FDA-approved treatments for ALS, but they offer only modest benefits in term of survival and functional decline. Noninvasive ventilation, nutritional support (including percutaneous endoscopic gastrostomy), and treatment of pseudobulbar affect by dextromethorphan-quinidine also have shown some benefit. Prognosis and goals of care should be discussed with the patient early in the disease course to avoid unwanted diagnostic and therapeutic measures."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"554f27",
"children":[
"Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease of motor neurons that causes progressive weakness, atrophy, and early death; 20% of patients with ALS will develop frontotemporal dementia."
]
},
{
"type":"keypoint",
"hlId":"d0c254",
"children":[
"Riluzole and edaravone are FDA-approved treatments for ALS, but they offer only modest benefits in term of survival and functional decline."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_4",
"title":{
"__html":"Neuromuscular Junction Disorders"
},
"titleNode":{
"type":"section-title",
"hlId":"5fef00",
"children":[
"Neuromuscular Junction Disorders"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_nr_s9_4_1",
"title":{
"__html":"Myasthenia Gravis"
},
"titleNode":{
"type":"section-title",
"hlId":"340529",
"children":[
"Myasthenia Gravis"
]
},
"children":[
{
"type":"p",
"hlId":"a8dd22",
"children":[
"Myasthenia gravis (MG) is an autoimmune disease of the postsynaptic neuromuscular junction associated with antibodies to acetylcholine receptors. Onset most commonly occurs in the third decade of life in women and after age 50 years in men. Ptosis and diplopia are the first manifestations in two thirds of patients, although only half of these patients develop generalized myasthenia, typically within 2 years. Early bulbar and cervical involvement is seen in 10% of patients. Fluctuating painless weakness without sensory loss is typical. Weakness may be missed on clinical examination unless fatigability is assessed by sustained or repeated activation of muscles. The presence of respiratory symptoms should prompt close monitoring of respiratory parameters because of the risk of rapid respiratory failure (myasthenic crisis). This crisis can occur as part of the natural history of bulbar or generalized myasthenia or be triggered by external factors, including infection, surgery, or certain medications (especially aminoglycosides, quinolones, magnesium, β-blockers, and hydroxychloroquine)."
]
},
{
"type":"p",
"hlId":"98fb78",
"children":[
"Diagnosis of MG is based on clinical, serologic, and EMG findings. Disease-specific antibodies are found in 90% of patients; of these, 85% have typical MG with acetylcholine receptor antibodies, but 5% have anti–muscle-specific kinase (MuSK) or anti–lipoprotein receptor-related protein 4 (LRP4) antibodies. MuSK-positive myasthenia is more likely to cause focal or severe bulbar, cervical, or respiratory weakness. The characteristic EMG finding of MG is a decremental response to repetitive stimulation. All patients with MG should undergo chest CT to screen for thymoma, a tumor associated with the disease."
]
},
{
"type":"p",
"hlId":"d921be",
"children":[
"Symptomatic treatment of ocular and mild generalized myasthenia usually starts with the cholinesterase inhibitor pyridostigmine. In those with more advanced disease, immunosuppressive therapy is required. Oral glucocorticoids often are used as first-line treatment but can cause transient exacerbation at high doses and should be titrated upward slowly in patients with mild to moderate weakness. In the presence of prominent bulbar or generalized weakness and in myasthenic crisis, treatment with IVIG or plasmapheresis should precede initiation of glucocorticoids because of the risk of triggering respiratory failure. The immunosuppressants azathioprine, mycophenolate mofetil, cyclosporine, and eculizumab are effective long-term maintenance therapies. However, these drugs have a delayed onset of action, and bridging therapy with concomitant glucocorticoids, IVIG, or plasmapheresis is usually required."
]
},
{
"type":"p",
"hlId":"58a79f",
"children":[
"Thymectomy should be performed in all patients with thymoma and offered as an option to (potentially) avoid or minimize immunotherapy in other patients with active disease who are younger than 65 years and within 3 years of diagnosis."
]
},
{
"type":"p",
"hlId":"0e8584",
"children":[
"MuSK-positive myasthenia responds well to plasmapheresis and glucocorticoids but requires aggressive maintenance immunosuppression. Prolonged remission has been reported with rituximab (off-label use); thymectomy and pyridostigmine are not helpful."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"a37d06",
"children":[
"Onset of myasthenia gravis (MG) most commonly occurs in the third decade of life in women and after age 50 years in men, with ptosis, diplopia, and fluctuating painless weakness without sensory loss being typical symptoms; all patients with MG should undergo chest CT to screen for thymoma, a tumor associated with the disease."
]
},
{
"type":"keypoint",
"hlId":"b5efe4",
"children":[
"Symptomatic treatment of ocular and mild generalized myasthenia gravis usually starts with the cholinesterase inhibitor pyridostigmine; in those with more advanced disease, immunosuppressive therapy is required, as is thymectomy for those with thymoma."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_4_2",
"title":{
"__html":"Lambert-Eaton Myasthenic Syndrome"
},
"titleNode":{
"type":"section-title",
"hlId":"95749e",
"children":[
"Lambert-Eaton Myasthenic Syndrome"
]
},
"children":[
{
"type":"p",
"hlId":"ab1250",
"children":[
"Lambert-Eaton myasthenic syndrome is an autoimmune disorder of the presynaptic neuromuscular junction associated with antibodies against the voltage-gated calcium channel. This disorder presents similarly to MG, except that weakness improves with exercise, and hyporeflexia and dysautonomia are present. Diagnosis is confirmed by detection of serum anti–voltage-gated calcium channel antibodies (90%) and the EMG finding of augmented motor response to rapid repetitive stimulation. Malignancy, especially small cell lung cancer, is found in half of patients. Treatment consists of treating any underlying malignancy or, in nonparaneoplastic disease, immunosuppression, IVIG, or plasmapheresis. Amifampridine can provide symptomatic benefit."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_5",
"title":{
"__html":"Myopathies"
},
"titleNode":{
"type":"section-title",
"hlId":"3518ad",
"children":[
"Myopathies"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_nr_s9_5_1",
"title":{
"__html":"Overview"
},
"titleNode":{
"type":"section-title",
"hlId":"3b8782",
"children":[
"Overview"
]
},
"children":[
{
"type":"p",
"hlId":"d2fe41",
"children":[
"Classification of myopathies is based on clinical and pathologic characteristics and acquired versus inherited causes ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t49",
"wrapId":"9",
"children":[
"Table 49"
]
}
]
},
")"
]
},
". Most myopathies involve symmetric weakness of the proximal limb muscles. A normal sensory and reflex examination can differentiate myopathy from neuropathy. Additional features that can indicate a specific diagnosis include the clinical course; the presence of pain and stiffness; atypical distribution in ocular, bulbar, or distal limb muscles; and episodic symptoms ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t50",
"wrapId":"9",
"children":[
"Table 50"
]
}
]
},
")"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"9",
"contentIds":[
"mk19_a_nr_t49",
"mk19_a_nr_t50"
]
},
{
"type":"p",
"hlId":"1a9b7d",
"children":[
"Diagnosis is based on systematic clinical assessment, muscle-related serum markers (creatine kinase [CK], aldolase), EMG findings, muscle biopsy, and, in certain cases, genetic testing. The serum CK level is elevated in many forms of myopathy and can be followed to monitor disease activity and response to treatment in inflammatory myopathies. Mild elevation of the serum CK level (<5 times normal) is not specific to myopathies and also can be seen in ALS, CIDP, muscle trauma, and persistent elevation of the serum CK level without weakness (benign hyperCKemia). EMG can confirm the presence of changes associated with myopathy (low amplitude, short duration, polyphasic shape of motor unit potentials). Muscle biopsy is the most helpful test to confirm the diagnosis of myopathy, but in some hereditary myopathies, genetic testing can provide the confirmation without need for biopsy."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"1849a6",
"children":[
"Diagnosis of a myopathy is based on systematic clinical assessment, muscle-related serum markers, electromyographic findings, muscle biopsy, and (sometimes) genetic testing."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_5_2",
"title":{
"__html":"Inflammatory Myopathy"
},
"titleNode":{
"type":"section-title",
"hlId":"bc179c",
"children":[
"Inflammatory Myopathy"
]
},
"children":[
{
"type":"p",
"hlId":"75fe71",
"children":[
"Polymyositis, dermatomyositis, immune-mediated necrotizing myopathy, and inclusion body myositis are idiopathic inflammatory myopathies. Polymyositis and dermatomyositis present with acute or subacute proximal muscle weakness. Inclusion body myositis has a slowly progressive course and causes early weakness and atrophy of distal upper extremity flexors, quadriceps, and bulbar muscles. Muscle biopsy reveals inflammation and characteristic inclusion bodies. See ",
{
"type":"cross-reference",
"target":"mk19_b_rm_s9",
"children":[
"MKSAP 19 Rheumatology"
]
},
" for further information on inflammatory myopathy."
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_5_3",
"title":{
"__html":"Endocrine-Related Myopathy"
},
"titleNode":{
"type":"section-title",
"hlId":"2ad31e",
"children":[
"Endocrine-Related Myopathy"
]
},
"children":[
{
"type":"p",
"hlId":"9aa53a",
"children":[
"Hypothyroid myopathy can cause diffuse myalgia, proximal weakness, and myoedema (muscle mounding after percussion). Hyperthyroidism also can cause myopathy in association with fasciculation (see ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"video-link",
"target":"mk19_a_nr_v06",
"wrapId":"10",
"children":[
"Video 6"
]
}
]
},
"), ophthalmoplegia and hyperreflexia. An excess of endogenous or exogenous glucocorticosteroids, parathyroid or pituitary dysfunction, and vitamin D deficiency are other endocrine causes of myopathy."
]
},
{
"type":"inline-wrap",
"wrapId":"10",
"contentIds":[
"mk19_a_nr_v06"
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_5_4",
"title":{
"__html":"Toxic Myopathy"
},
"titleNode":{
"type":"section-title",
"hlId":"613377",
"children":[
"Toxic Myopathy"
]
},
"children":[
{
"type":"p",
"hlId":"c5b1c4",
"children":[
"Toxic myopathy can be triggered by statins and other drugs (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t49",
"wrapId":"11",
"children":[
"Table 49"
]
}
]
},
")"
]
},
". Statins can cause a spectrum of symptoms, ranging from mild myalgia to myopathy to rare cases of rhabdomyolysis. The risk of myopathy increases with higher dosages, the addition of fenofibrate or gemfibrozil, the addition of cytochrome P450 3A4 isozyme inhibitors, and the use of lipophilic statins (simvastatin, atorvastatin, and lovastatin). Discontinuation of these agents should be considered if serum CK level is elevated (typically, >5-10 times the upper limit of normal) or in patients with weakness or severe pain. In patients deemed to significantly benefit from statins, retrial with a different statin should be considered after resolution of muscle symptoms, with continued monitoring of the CK level. A small subset of patients develops a necrotizing myositis that continues to progress after discontinuation of statins. These patients have a serum antibody to hydroxymethylglutaryl–coenzyme A receptor and may respond to immunosuppression."
]
},
{
"type":"inline-wrap",
"wrapId":"11",
"contentIds":[
"mk19_a_nr_t49"
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_5_5",
"title":{
"__html":"Inherited Myopathies"
},
"titleNode":{
"type":"section-title",
"hlId":"3522ef",
"children":[
"Inherited Myopathies"
]
},
"children":[
{
"type":"p",
"hlId":"b90f57",
"children":[
"Inherited myopathies are listed in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t49",
"wrapId":"12",
"children":[
"Table 49"
]
}
]
},
". Many of these disorders develop early in life, but some present in adulthood. Myotonic dystrophies are systemic diseases associated with myotonia, an impairment of muscle relaxation causing stiffness and a delayed hand-grip release. Myotonic dystrophy type 1 causes distal weakness and is associated with cataracts, frontal balding, cardiac and endocrine disease, and mild cognitive impairment. Progression of weakness is slow, but diagnosis should prompt close monitoring for cardiac and pulmonary disease that can cause premature mortality."
]
},
{
"type":"inline-wrap",
"wrapId":"12",
"contentIds":[
"mk19_a_nr_t49"
]
},
{
"type":"p",
"hlId":"924c9e",
"children":[
"Mitochondrial myopathy presents with significant variability and can cause fatigue, myalgia, ophthalmoplegia, and various extramuscular manifestations. Mitochondrial myopathies should be suspected in the presence of a fluctuating course, multiorgan involvement, and maternal transmission."
]
},
{
"type":"p",
"hlId":"499206",
"children":[
"Adult-onset metabolic myopathies may present with isolated exercise-induced weakness, cramps, and myoglobinuria and include many deficiencies of key metabolic pathways, such as glycogen storage and fatty acid oxidation; the most common types are carnitine palmitoyltransferase II deficiency and McArdle disease."
]
},
{
"type":"p",
"hlId":"6a66a6",
"children":[
"Acid maltase deficiency (Pompe disease) has an adult-onset form associated with proximal and respiratory muscle weakness. Diagnosis is based on assessment of α-glucosidase activity and genetic testing. Alglucosidase alfa is FDA approved to prevent progression of weakness."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s9_6",
"bibliography":true,
"title":{
"__html":"Bibliography"
},
"titleNode":{
"type":"section-title",
"hlId":"a7cc81",
"children":[
"Bibliography"
]
},
"children":[
{
"type":"references",
"children":[
{
"type":"reference",
"children":[
"Barohn R, Amato A. Pattern-recognition approach to neuropathy and neuronopathy. Neurol Clin. 2013 May;31(2):343-61. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/23642713",
"target":"_blank"
},
"children":[
"PMID: 23642713"
]
},
" doi:10.1016/j.ncl.2013.02.001."
]
},
{
"type":"reference",
"children":[
"Brown R, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017 Jul 13;377(2):162-72. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28700839",
"target":"_blank"
},
"children":[
"PMID: 28700839"
]
},
" doi:10.1056/NEJMra1603471."
]
},
{
"type":"reference",
"children":[
"Bunschoten C, Jacobs B, Van den Bergh P, et al. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Lancet Neurol. 2019 Aug;18(8):784-94. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31076244",
"target":"_blank"
},
"children":[
"PMID: 31076244"
]
},
" doi:10.1016/S1474-4422(19)30144-9."
]
},
{
"type":"reference",
"children":[
"Doughty C, Bowley M. Entrapment neuropathies of the upper extremity. Med Clin North Am. 2019 Mar;103(2):357-70. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30704687",
"target":"_blank"
},
"children":[
"PMID: 30704687"
]
},
" doi:10.1016/j.mcna.2018.10.012."
]
},
{
"type":"reference",
"children":[
"Edmundson C, Bird SJ. Acute Manifestations of Neuromuscular Disease. Semin Neurol. 2019;39:115-124. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30743297",
"target":"_blank"
},
"children":[
"PMID: 30743297"
]
},
" doi:10.1055/s-0038-1676838"
]
},
{
"type":"reference",
"children":[
"Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5:41. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31197153",
"target":"_blank"
},
"children":[
"PMID: 31197153"
]
},
" doi:10.1038/s41572-019-0092-1"
]
},
{
"type":"reference",
"children":[
"Narayanaswami P, Sanders DB, Wolfe G, et al. International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update. Neurology. 2021;96:114-122. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/33144515",
"target":"_blank"
},
"children":[
"PMID: 33144515"
]
},
" doi:10.1212/WNL.0000000000011124"
]
},
{
"type":"reference",
"children":[
"Hilton-Jones D. Statin-related myopathies. Pract Neurol. 2018 Apr;18(2):97-105. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/29496886",
"target":"_blank"
},
"children":[
"PMID: 29496886"
]
},
" doi:10.1136/practneurol-2017-001738."
]
},
{
"type":"reference",
"children":[
"Novak P. Autonomic disorders. Am J Med. 2019 Apr;132(4):420-36. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30308186",
"target":"_blank"
},
"children":[
"PMID: 30308186"
]
},
" doi:10.1016/j.amjmed.2018.09.027."
]
},
{
"type":"reference",
"children":[
"Willison H, Jacobs B, van Doorn P. Guillain-Barré syndrome. Lancet. 2016 Aug 13;388(10045):717-27. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/26948435",
"target":"_blank"
},
"children":[
"PMID: 26948435"
]
},
" doi:10.1016/S0140-6736(16)00339-1."
]
}
]
}
]
}
]
},
"tablesContent":{
"mk19_a_nr_t44":{
"id":"mk19_a_nr_t44",
"number":44,
"bookId":"nr",
"title":{
"__html":"Features Distinguishing Peripheral from Central Nervous System Disorders"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"0ae60f",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 44. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t44"
}
]
},
"Features Distinguishing Peripheral from Central Nervous System Disorders"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"98f770",
"class":"col hd l",
"children":[
"Features"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e12b39",
"class":"col hd l",
"children":[
"PNS Disorder"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"34d3e8",
"class":"col hd l",
"children":[
"CNS Disorder"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"598f11",
"class":"cell txt l",
"children":[
"Onset"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a19a54",
"class":"cell txt l",
"children":[
"Subacute or insidious"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c6ba32",
"class":"cell txt l",
"children":[
"Sudden (stroke) or gradual (mass lesions)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"582c2a",
"class":"cell txt l",
"children":[
"Pattern of weakness"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"eee377",
"class":"cell txt l",
"children":[
"Focal or multifocal (in the territory of the affected nerve, plexus, or root) or generalized"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e04ac6",
"class":"cell txt l",
"children":[
"Entire limb, unilateral, or a pyramidal pattern of weakness",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"924937",
"class":"cell txt l",
"children":[
"Atrophy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"80db83",
"class":"cell txt l",
"children":[
"Yes (at times prominent)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ed01b1",
"class":"cell txt l",
"children":[
"No (or mild, and related to disuse)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"620fcf",
"class":"cell txt l",
"children":[
"Fasciculations"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"93cba0",
"class":"cell txt l",
"children":[
"Yes"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bafd73",
"class":"cell txt l",
"children":[
"No"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fc32b1",
"class":"cell txt l",
"children":[
"Tone"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"372aa5",
"class":"cell txt l",
"children":[
"Decreased or normal"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"44d1cb",
"class":"cell txt l",
"children":[
"Increased (spasticity or rigidity",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
") or normal"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fa4f0c",
"class":"cell txt l",
"children":[
"Pattern of sensory symptoms"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"72ed41",
"class":"cell txt l",
"children":[
"Focal or multifocal (in the territory of the affected nerve, plexus, or root) or stocking-glove in distribution"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"83fced",
"class":"cell txt l",
"children":[
"Entire limb or unilateral"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7bdbc5",
"class":"cell txt l",
"children":[
"Type of sensory symptoms"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8e6e56",
"class":"cell txt l",
"children":[
"Positive symptoms (paresthesia, dysesthesia, or allodynia",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
},
") more frequent, but negative symptoms (numbness) possible"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9e8648",
"class":"cell txt l",
"children":[
"Negative symptoms more frequent, but positive symptoms possible"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f30e8f",
"class":"cell txt l",
"children":[
"Dissociated sensory loss"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3f85ad",
"class":"cell txt l",
"children":[
"Pain/temperature and vibration/proprioception deficits travel together"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dc4364",
"class":"cell txt l",
"children":[
"Dissociation of pain/temperature and vibration/proprioception deficits possible with spinal and brainstem lesions"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b32315",
"class":"cell txt l",
"children":[
"Deep tendon reflexes"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"05ee5f",
"class":"cell txt l",
"children":[
"Diminished or normal"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e72433",
"class":"cell txt l",
"children":[
"Increased"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-10 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"81e060",
"class":"cell txt l",
"children":[
"Pathologic reflexes"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e384f0",
"class":"cell txt l",
"children":[
"Absent"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ce0a1e",
"class":"cell txt l",
"children":[
"Present, including extensor plantar response, Hoffman sign,",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"d"
]
},
" knee cross adduction response, jaw jerk reflex, snout reflex, and clonus"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-11 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f4a4b3",
"class":"cell txt l",
"children":[
"Additional localizing symptoms"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"19e86d",
"class":"cell txt l",
"children":[
"Cramps"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9a954a",
"class":"cell txt l",
"children":[
"Headache, seizures, and visual and language-related symptoms"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-12 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5d8512",
"class":"cell txt l",
"children":[
"EMG"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"017de7",
"class":"cell txt l",
"children":[
"Abnormal"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"960b44",
"class":"cell txt l",
"children":[
"Normal"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"CNS = central nervous system; EMG = electromyography; PNS = peripheral nervous system."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Pyramidal weakness is caused by upper motor neuron lesions and affects extensors more than flexors in the upper limbs and flexors more than extensors in the lower limbs."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"Spasticity is a direction- and velocity-dependent increase in tone and is associated with pyramidal lesions; rigidity is an increase in tone that is independent of velocity and direction and is associated with extrapyramidal lesions."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
},
"Paresthesia is an abnormal spontaneous sensation, such as tingling, burning, or electrical sensation. Dysesthesia is an unpleasant sensation provoked by neutral stimuli, such as light touch or contact of clothes. Allodynia is pain provoked by nonnoxious stimuli."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"d"
]
},
"Hoffman sign is positive if the thumb is flexed in response to a flicking or snapping of the distal phalanx of the middle finger."
]
]
},
"mk19_a_nr_t45":{
"id":"mk19_a_nr_t45",
"number":45,
"bookId":"nr",
"title":{
"__html":"Classification of Neuromuscular Disorders"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"544f8e",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 45. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t45"
}
]
},
"Classification of Neuromuscular Disorders"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a1fa27",
"class":"col hd l",
"children":[
"Type"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"98f770",
"class":"col hd l",
"children":[
"Features"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ff7c0f",
"class":"col hd l",
"children":[
"Examples"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c59dba",
"class":"cell txt l",
"children":[
"Myopathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0a5548",
"class":"cell txt li",
"children":[
"Acquired"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0354f4",
"class":"cell txt l",
"children":[
"Proximal greater than distal weakness, absence of sensory and autonomic symptoms, symmetric, late hyporeflexia after atrophy, adult onset"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c2ec1b",
"class":"cell txt l",
"children":[
"Inflammatory, toxic, systemic, and endocrine myopathies"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b0b517",
"class":"cell txt li",
"children":[
"Inherited"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b7288d",
"class":"cell txt l",
"children":[
"Similar to acquired myopathy, onset in childhood or early adulthood, positive family history, some possibly associated with distal or multifocal (scapuloperoneal, oculopharyngeal) weakness and atrophy, myotonia, or exercise-induced pain"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9a2897",
"class":"cell txt l",
"children":[
"Muscular dystrophies; mitochondrial, metabolic, and congenital myopathies"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f9b390",
"class":"cell txt l",
"children":[
"Neuromuscular junction disorder"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0ab777",
"class":"cell txt l",
"children":[
"Fluctuating weakness; fatigue; absence of sensory and autonomic symptoms; symmetric, bulbar, and respiratory involvement"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cf6f9e",
"class":"cell txt l",
"children":[
"Myasthenia gravis, Lambert-Eaton myasthenic syndrome"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"efb81f",
"class":"cell txt l",
"children":[
"Peripheral neuropathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c51b0e",
"class":"cell txt li",
"children":[
"Axonal"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"092bbe",
"class":"cell txt l",
"children":[
"Symmetric distal sensory and sensorimotor impairment, possible involvement of autonomic nerves, early or late hyporeflexia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9ee6cc",
"class":"cell txt l",
"children":[
"Diabetic, toxic, hypothyroid, uremic, and nutritional polyneuropathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bfab6f",
"class":"cell txt li",
"children":[
"Demyelinating"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6fd1df",
"class":"cell txt l",
"children":[
"Proximal and distal symmetric or multifocal weakness with variable sensory loss, early areflexia, low back radicular pain; hereditary forms associated with foot deformities and slow progression"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"22504b",
"class":"cell txt l",
"children":[
"GBS, CIDP, hereditary (CMT1)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bdfb6e",
"class":"cell txt li",
"children":[
"Mononeuropathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3a1ee7",
"class":"cell txt l",
"children":[
"Sensory and motor deficits within the distribution of a single nerve, symptoms distal to site of compression"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c0366f",
"class":"cell txt l",
"children":[
"Carpal tunnel syndrome, ulnar neuropathy, radial neuropathy, peroneal neuropathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"625212",
"class":"cell txt l",
"children":[
"Plexopathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"123482",
"class":"cell txt l",
"children":[
"Motor and sensory deficits in multiple contiguous nerves in upper or lower extremities, asymmetric, severe pain at onset with autoimmune and diabetic types"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c53e04",
"class":"cell txt l",
"children":[
"Idiopathic brachial plexitis, idiopathic lumbosacral radiculoplexus neuropathy, diabetic amyotrophy, postradiation and carcinomatous plexopathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"813023",
"class":"cell txt l",
"children":[
"Radiculopathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d7187b",
"class":"cell txt l",
"children":[
"Motor, sensory, and reflex deficits in the area innervated by affected nerve root, radicular pain and paresthesia, neck or low back pain"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d4b5ee",
"class":"cell txt l",
"children":[
"Cervical and lumbar radiculopathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bfb4a3",
"class":"cell txt l",
"children":[
"Ganglionopathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0e6a1f",
"class":"cell txt l",
"children":[
"Severe loss of vibration and joint position sense in single limb, no motor deficit"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1b6cdd",
"class":"cell txt l",
"children":[
"Paraneoplastic and autoimmune ganglionopathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"132ddb",
"class":"cell txt l",
"children":[
"Motor neuron disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1f4c26",
"class":"cell txt l",
"children":[
"Concomitant signs of upper motor neuron (hyperreflexia, pyramidal signs, and spasticity) and lower motor neuron (weakness, atrophy, and fasciculation) dysfunction, no sensory deficit, asymmetric onset, bulbar and respiratory involvement"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6d9162",
"class":"cell txt l",
"children":[
"Amyotrophic lateral sclerosis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2272d7",
"class":"cell txt l",
"children":[
"Myelopathy",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5e26f3",
"class":"cell txt l",
"children":[
"Lower motor neuron signs at the level of compression and upper motor neuron signs below it, sphincter dysfunction, sensory symptoms present, sensory level"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"80f226",
"class":"cell txt l",
"children":[
"Cervical cord compression"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"CIDP = chronic inflammatory demyelinating polyradiculoneuropathy; CMT1 = Charcot-Marie-Tooth disease type 1; GBS = Guillain-Barré syndrome."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Myelopathy is a key differential diagnosis for neuromuscular disorders."
]
]
},
"mk19_a_nr_t46":{
"id":"mk19_a_nr_t46",
"number":46,
"bookId":"nr",
"title":{
"__html":"Common Symptoms and Signs of Neuromuscular Disorders"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"12c422",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 46. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t46"
}
]
},
"Common Symptoms and Signs of Neuromuscular Disorders"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9af665",
"class":"col hd l",
"children":[
"Symptoms and Signs"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a44fd1",
"class":"col hd l",
"children":[
"Differential Diagnosis"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bc1d14",
"class":"cell txt l",
"children":[
"Weakness"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4cf323",
"class":"cell txt li",
"children":[
"Distal extremities"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9dc973",
"class":"cell txt l",
"children":[
"Diabetic, toxic and systemic polyneuropathy, hereditary neuropathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1717e1",
"class":"cell txt li",
"children":[
"Proximal extremities"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"145971",
"class":"cell txt l",
"children":[
"Myopathy, polyradiculopathy, inflammatory demyelinating neuropathy, diabetic amyotrophy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8787a6",
"class":"cell txt li",
"children":[
"Multifocal with pain (mononeuropathy multiplex)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bbe553",
"class":"cell txt l",
"children":[
"Vasculitis, rheumatoid arthritis, diabetes"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b58356",
"class":"cell txt li",
"children":[
"Focal asymmetric"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b728c7",
"class":"cell txt l",
"children":[
"ALS, inclusion body myositis, radiculopathy, mononeuropathy, multifocal motor neuropathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"764e80",
"class":"cell txt li",
"children":[
"Fluctuating"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2942f9",
"class":"cell txt l",
"children":[
"Myasthenia gravis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7d2614",
"class":"cell txt li",
"children":[
"Muscles of eye movement"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"11781a",
"class":"cell txt l",
"children":[
"Myasthenia gravis, mitochondrial myopathy, thyroid disease"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"06760d",
"class":"cell txt li",
"children":[
"Bulbar (tongue, palate, lips)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"be8ff6",
"class":"cell txt l",
"children":[
"ALS, myasthenia gravis, inclusion body myositis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b650b0",
"class":"cell txt li",
"children":[
"Cranial nerves (especially seventh and third)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2b7a83",
"class":"cell txt l",
"children":[
"Diabetes, Lyme disease, sarcoidosis, HIV infection, Sjögren syndrome, tuberculosis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"01ef1d",
"class":"cell txt li",
"children":[
"Neck extensors"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fa378e",
"class":"cell txt l",
"children":[
"ALS, myasthenia gravis (especially with anti-MuSK antibody), inflammatory myopathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"77c718",
"class":"cell txt li",
"children":[
"Fasciculation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"aefee3",
"class":"cell txt l",
"children":[
"ALS, radiculopathy, benign fasciculation syndrome"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"006bd8",
"class":"cell txt l",
"children":[
"Sensory"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f8fc73",
"class":"cell txt li",
"children":[
"Stocking-glove gradient"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b0b384",
"class":"cell txt l",
"children":[
"Diabetic, toxic, systemic, or cryptogenic polyneuropathy; hereditary neuropathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"788fcc",
"class":"cell txt li",
"children":[
"Dermatomal pattern"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d9b402",
"class":"cell txt l",
"children":[
"Radiculopathy, mononeuropathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"31776c",
"class":"cell txt li",
"children":[
"Distal pain without hyporeflexia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"446be9",
"class":"cell txt l",
"children":[
"Small fiber neuropathy (diabetes mellitus, alcoholism, Sjögren syndrome, sarcoidosis, HIV, hepatitis C)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"10fe13",
"class":"cell txt li",
"children":[
"Marked proprioceptive loss in single limb"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8e7ff2",
"class":"cell txt l",
"children":[
"Dorsal root ganglionopathy (paraneoplastic, Sjögren syndrome, HIV)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a2ac9f",
"class":"cell txt l",
"children":[
"Autonomic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cf4208",
"class":"cell txt li",
"children":[
"Orthostatic hypotension, resting tachycardia, excessive or impaired sweating, gastroparesis, constipation, erectile dysfunction"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"95bbe9",
"class":"cell txt l",
"children":[
"Diabetes, alcoholism, amyloidosis, autoimmune dysautonomia with anti–ganglionic acetylcholine receptor antibody, paraneoplastic antibodies"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"ALS = amyotrophic lateral sclerosis; MuSK = muscle-specific kinase."
]
]
},
"mk19_a_nr_t47":{
"id":"mk19_a_nr_t47",
"number":47,
"bookId":"nr",
"title":{
"__html":"Laboratory Testing in Peripheral Neuropathy"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"b6c496",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 47. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t47"
}
]
},
"Laboratory Testing in Peripheral Neuropathy"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1af15c",
"class":"col hd l",
"children":[
"Underlying Cause"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6f071b",
"class":"col hd l",
"children":[
"Clinical Presentation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8d90a3",
"class":"col hd l",
"children":[
"Laboratory Testing"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"84490f",
"class":"cell txt l",
"children":[
"Diabetes mellitus, impaired glucose tolerance"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"12e021",
"class":"cell txt l",
"children":[
"Distal symmetric polyneuropathy, mononeuropathy, lumbosacral radiculoneuropathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7d6bbe",
"class":"cell txt l",
"children":[
"Fasting plasma glucose level, glucose tolerance test, hemoglobin A",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1c"
]
},
" measurement"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"13acca",
"class":"cell txt l",
"children":[
"Uremia, thyroid disease, anemia, liver disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3c1a99",
"class":"cell txt l",
"children":[
"Distal symmetric polyneuropathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a3162a",
"class":"cell txt l",
"children":[
"Serum creatinine, TSH, and free thyroxine (T",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"4"
]
},
") levels; hematocrit, liver chemistry tests"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8bb666",
"class":"cell txt l",
"children":[
"Connective tissue disease, polyarteritis nodosa, vasculitis, Sjögren syndrome, cryoglobulinemia, IgG4-related disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ff2b75",
"class":"cell txt l",
"children":[
"Vasculitic mononeuropathy multiplex, Sjögren ganglionopathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ca4a83",
"class":"cell txt l",
"children":[
"ESR and rheumatoid factor determination; antinuclear antibody, ANCA, anti-Ro/SSA antibody, anti–LA/SSB antibody, cryoglobulin, and serum IgG4 level measurements"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fd36aa",
"class":"cell txt l",
"children":[
"Syphilis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"eddba1",
"class":"cell txt l",
"children":[
"Posterior column disease resembling large-fiber neuropathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"85e5ac",
"class":"cell txt l",
"children":[
"RPR, CSF, VDRL"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e59c25",
"class":"cell txt l",
"children":[
"MGUS, amyloidosis, multiple myeloma, lymphoproliferative disease, POEMS syndrome"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"38376e",
"class":"cell txt l",
"children":[
"Paraproteinemic neuropathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7d2ec1",
"class":"cell txt l",
"children":[
"SPEP, UPEP, IFE, serum free light chain assay"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"70e5d5",
"class":"cell txt l",
"children":[
"Vitamin B",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"12"
]
},
", folate, vitamin E, or copper deficiency"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0e0ccf",
"class":"cell txt l",
"children":[
"Myeloneuropathy with brisk reflexes"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dd190e",
"class":"cell txt l",
"children":[
"Serum copper, vitamin B",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"12"
]
},
", folate, vitamin E, methylmalonic acid/homocysteine levels"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5d2638",
"class":"cell txt l",
"children":[
"CIDP, GBS"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e26bee",
"class":"cell txt l",
"children":[
"Subacute or acute progressive symmetric proximal and distal motor and sensory polyradiculoneuropathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1fbc21",
"class":"cell txt l",
"children":[
"CSF cells and protein, serum antiganglioside antibodies"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"960f11",
"class":"cell txt l",
"children":[
"Miller-Fisher variant of GBS"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"eaebd9",
"class":"cell txt l",
"children":[
"Ophthalmoplegia, ataxia, areflexia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b187ac",
"class":"cell txt l",
"children":[
"Serum anti-GQ1B antibody"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f608fd",
"class":"cell txt l",
"children":[
"Multifocal motor neuropathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"72de03",
"class":"cell txt l",
"children":[
"Asymmetric pure motor weakness"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"aa2540",
"class":"cell txt l",
"children":[
"Serum anti-GM1 antibody"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-10 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e3d6a6",
"class":"cell txt l",
"children":[
"Distal acquired demyelinating symmetric neuropathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7d2fb7",
"class":"cell txt l",
"children":[
"Distal sensory loss, tremor, sensory ataxia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8bfcf5",
"class":"cell txt l",
"children":[
"SPEP, IFE, serum anti-MAG antibody"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-11 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"97fa04",
"class":"cell txt l",
"children":[
"Amyloidosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"735443",
"class":"cell txt l",
"children":[
"Autonomic and small-fiber neuropathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"871e97",
"class":"cell txt l",
"children":[
"Serum free light chains, abdominal fat pad biopsy, transthyretin gene testing (familial)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-12 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"aee256",
"class":"cell txt l",
"children":[
"Infectious neuropathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"326e03",
"class":"cell txt l",
"children":[
"Variable, cranial nerve palsy, myelopathy with flaccid weakness in West Nile virus"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f84f56",
"class":"cell txt l",
"children":[
"Fourth-generation combination HIV assay, serum Lyme antibody with Western blot confirmation, CSF West Nile virus antibody, skin biopsy in leprosy, IGRA, CSF acid-fast smear"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-13 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d03580",
"class":"cell txt l",
"children":[
"Toxic neuropathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"539d43",
"class":"cell txt l",
"children":[
"Symmetric sensory or sensorimotor neuropathy, acute motor neuropathy (lead)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"51d655",
"class":"cell txt l",
"children":[
"Serum lead, arsenic, mercury, and thallium measurements; 24-hour urine toxicology; history of exposure to ethanol, chemotherapy agents, colchicine, amiodarone, quinolones"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-14 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6b2970",
"class":"cell txt l",
"children":[
"Celiac disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cf122e",
"class":"cell txt l",
"children":[
"Sensory neuropathy and ataxia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"58994b",
"class":"cell txt l",
"children":[
"IgA tissue transglutaminase antibodies"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-15 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"508d17",
"class":"cell txt l",
"children":[
"Porphyria"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b9ab1a",
"class":"cell txt l",
"children":[
"Acute painful polyradiculopathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"824598",
"class":"cell txt l",
"children":[
"Urine porphobilinogen and δ-aminolevulinic acid"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-16 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"177fbe",
"class":"cell txt l",
"children":[
"Paraneoplastic disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fb2d84",
"class":"cell txt l",
"children":[
"Subacute progressive sensory neuropathy, asymmetric ganglionopathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e2a946",
"class":"cell txt l",
"children":[
"Serum anti-Hu and anti-CRMP5 measurement; CSF oligoclonal bands determination; assessment for underlying malignancy"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"ANCA = antineutrophil cytoplasmic antibody; CIDP = chronic inflammatory demyelinating polyradiculoneuropathy; CRMP5 = collapsin response mediator protein 5; CSF = cerebrospinal fluid; ESR = erythrocyte sedimentation rate; GBS = Guillain-Barré syndrome, IFE = immune fixation electrophoresis; IGRA = interferon-γ release assay; MAG = myelin-associated glycoprotein; MGUS = monoclonal gammopathy of unknown significance; POEMS = polyneuropathy, organomegaly, endocrinopathy, monoclonal protein plasma cell disorder, and skin lesions; RPR = rapid plasma reagin; SPEP = serum protein electrophoresis; SSA = Sjögren syndrome–related antigen A; SSB = Sjögren syndrome–related antigen B; TSH = thyroid-stimulating hormone; UPEP = urine protein electrophoresis; VDRL = Venereal Disease Research Laboratory test."
]
]
},
"mk19_a_nr_t48":{
"id":"mk19_a_nr_t48",
"number":48,
"bookId":"nr",
"title":{
"__html":"Peripheral Nerve Dysfunction in Diabetes Mellitus"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"9dd70f",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 48. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t48"
}
]
},
"Peripheral Nerve Dysfunction in Diabetes Mellitus"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5c9335",
"class":"col hd l",
"children":[
"Classification"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cce2ee",
"class":"col hd l",
"children":[
"Sign and Symptoms"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"523223",
"class":"col hd l",
"children":[
"Diagnosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fe4dbc",
"class":"col hd l",
"children":[
"Management"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"334d58",
"class":"cell txt l",
"children":[
"Autonomic neuropathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"256f2a",
"class":"cell txt l",
"children":[
"Orthostatic hypotension, early satiety, nausea and vomiting (gastroparesis), constipation (colonic dysmotility), erectile dysfunction, hyperhidrosis or hypohidrosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6d14d7",
"class":"cell txt l",
"children":[
"Orthostatic blood pressure determination, QSART, tilt table"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"77aa51",
"class":"cell txt l",
"children":[
"Fludrocortisone; midodrine; compression stocking; small frequent meals for gastroparesis; supportive management of bowel, bladder, and sexual symptoms; glycemic control"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8632ec",
"class":"cell txt l",
"children":[
"Diabetic lumbosacral radiculoneuropathy (diabetic amyotrophy)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"90dc39",
"class":"cell txt l",
"children":[
"Severe pain followed by weakness and muscle wasting in proximal lower extremities; weight loss, with or without proximal sensory loss"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a5b278",
"class":"cell txt l",
"children":[
"Clinical examination, EMG, lumbar spinal MRI, CT of abdomen and pelvis (to rule out retroperitoneal hematoma)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6eecf3",
"class":"cell txt l",
"children":[
"Pain control, physical therapy, supportive measures, not associated with level of glycemic control, not responsive to immunotherapy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bdfb6e",
"class":"cell txt l",
"children":[
"Mononeuropathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cadc09",
"class":"cell txt l",
"children":[
"Sensory loss; paresthesia or pain in the distribution of a single nerve, followed by weakness (median or peroneal nerve); cranial nerve palsy (especially cranial nerves III, VI, or VII)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2247fd",
"class":"cell txt l",
"children":[
"Clinical examination, EMG, brain MRI"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e88fdd",
"class":"cell txt l",
"children":[
"Avoidance of compressive positions, bracing, pain control, decompressive surgery, observation in cranial palsies"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"813023",
"class":"cell txt l",
"children":[
"Radiculopathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f84526",
"class":"cell txt l",
"children":[
"Sensory loss, pain, and weakness in the distribution of nerve roots; thoracic radiculopathy causing patchy truncal numbness is common"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"49aab2",
"class":"cell txt l",
"children":[
"Clinical examination, EMG, MRI of nerve roots (to rule out root compression)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"76b698",
"class":"cell txt l",
"children":[
"Pain control, glycemic control, observation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"28d775",
"class":"cell txt l",
"children":[
"Sensorimotor peripheral neuropathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"295a4a",
"class":"cell txt l",
"children":[
"Asymptomatic (sometimes), distal length dependent, sensory loss and weakness, often painful, possible loss of ankle reflex"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"04613c",
"class":"cell txt l",
"children":[
"Clinical, EMG"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b6d810",
"class":"cell txt l",
"children":[
"Regular monitoring of feet, supportive measures, neuropathic pain medication (see Small-fiber neuropathy below)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a26403",
"class":"cell txt l",
"children":[
"Small-fiber neuropathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3de1f5",
"class":"cell txt l",
"children":[
"Burning distal extremity pain without weakness, may be non–length-dependent, sparing of ankle reflex"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bd9890",
"class":"cell txt l",
"children":[
"Clinical, QSART, skin biopsy (intraepidermal nerve fiber density)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"02b485",
"class":"cell txt l",
"children":[
"Pregabalin, duloxetine, tapentadol (all FDA-approved); gabapentin, tricyclic antidepressants, venlafaxine, oxcarbazepine, topical capsaicin, tramadol"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"EMG = electromyography; QSART = quantitative sudomotor axon reflex test."
]
]
},
"mk19_a_nr_t49":{
"id":"mk19_a_nr_t49",
"number":49,
"bookId":"nr",
"title":{
"__html":"Classification of Myopathies"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"8ac606",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 49. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t49"
}
]
},
"Classification of Myopathies"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9bd813",
"class":"col hd l",
"children":[
"Class"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ff7c0f",
"class":"col hd l",
"children":[
"Examples"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"98f770",
"class":"col hd l",
"children":[
"Features"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5fa2e3",
"class":"cell txt l",
"children":[
"Inherited myopathies"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ed9ec4",
"class":"cell txt li",
"children":[
"Muscular dystrophies"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"382f80",
"class":"cell txt l",
"children":[
"Duchenne"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d0e223",
"class":"cell txt l",
"children":[
"Early onset, fulminant"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt li",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b0e995",
"class":"cell txt l",
"children":[
"Becker, Emery-Dreifuss"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e01583",
"class":"cell txt l",
"children":[
"Early onset, survival to adulthood, cardiac disease"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt li",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e4f7e3",
"class":"cell txt l",
"children":[
"Limb-girdle, facioscapulohumeral, oculopharyngeal"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"834374",
"class":"cell txt l",
"children":[
"Variable onset, slow course"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6edf78",
"class":"cell txt li",
"children":[
"Myotonic dystrophy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a5cd0f",
"class":"cell txt l",
"children":[
"Type 1"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"740072",
"class":"cell txt l",
"children":[
"Myotonia, distal weakness, ptosis with lower facial weakness, variable cognitive impairment, cataract, arrhythmia with cardiomyopathy, diabetes mellitus, thyroid disease"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt li",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1a4d85",
"class":"cell txt l",
"children":[
"Type 2"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e5dda4",
"class":"cell txt l",
"children":[
"Myotonia, proximal weakness, milder course, systemic features similar to those of type 1"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"aef909",
"class":"cell txt l",
"children":[
"Congenital myopathies"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"49f74f",
"class":"cell txt l",
"children":[
"Nemaline myopathy, centronuclear myopathy, central core myopathy, distal myopathies"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d2544f",
"class":"cell txt l",
"children":[
"Childhood onset, focal weakness in distal forms, predisposition to exercise-induced cramping and malignant hyperthermia in central core myopathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"559a19",
"class":"cell txt l",
"children":[
"Metabolic myopathies"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4cc089",
"class":"cell txt l",
"children":[
"Acid maltase deficiency (Pompe disease), CPT II deficiency, McArdle disease (myophosphorylase deficiency), other lipid and glycogen storage disorders"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"aaeae1",
"class":"cell txt l",
"children":[
"Exercise intolerance, myoglobinuria, myalgia, progressive proximal and respiratory weakness in acid maltase deficiency"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b8a460",
"class":"cell txt l",
"children":[
"Mitochondrial myopathies"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a88883",
"class":"cell txt l",
"children":[
"MERRF, MELAS, MNGIE, Kearns-Sayre syndrome"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d9b4aa",
"class":"cell txt l",
"children":[
"Childhood or early adulthood onset, fluctuating course, wide spectrum with variable systemic comorbidity, ophthalmoplegia, bulbar symptoms, elevated plasma lactic acid level"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"81d32a",
"class":"cell txt l",
"children":[
"Acquired myopathies"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"299540",
"class":"cell txt li",
"children":[
"Inflammatory"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"999ee4",
"class":"cell txt l",
"children":[
"Dermatomyositis, polymyositis, immune-mediated necrotizing myopathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"15c7b2",
"class":"cell txt l",
"children":[
"Highly elevated creatine kinase level, subacute course, association with malignancy, dermatologic signs in dermatomyositis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt li",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4a803d",
"class":"cell txt l",
"children":[
"Inclusion body myositis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8ace07",
"class":"cell txt l",
"children":[
"Onset usually after age 50 years, asymmetric progressive weakness with atrophy, distal arm and quadriceps involvement"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"626f5f",
"class":"cell txt li",
"children":[
"Endocrine-related"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bfa768",
"class":"cell txt l",
"children":[
"Hypothyroidism, hyperthyroidism, hyperparathyroidism, Addison disease, Cushing syndrome, acromegaly, vitamin D deficiency, hypokalemia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b0d75c",
"class":"cell txt li",
"children":[
"Systemic disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2a3503",
"class":"cell txt l",
"children":[
"Systemic lupus erythematosus, mixed connective tissue disease, systemic sclerosis, critical illness, paraneoplastic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"927d7b",
"class":"cell txt li",
"children":[
"Toxic and drug-related"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d6ea03",
"class":"cell txt l",
"children":[
"Ethanol, statins, gemfibrozil, fenofibrate, ezetimibe, glucocorticoids, anti-HIV and antimalarial agents, interferons, amphotericin B, amiodarone, immunophilins, immune checkpoint inhibitors"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dbefbc",
"class":"cell txt l",
"children":[
"Statin myopathy as possible cause of mildly to highly elevated creatine kinase level"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"CPT II deficiency = carnitine palmitoyltransferase II deficiency; MELAS = mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome; MERRF = myoclonic epilepsy with ragged red fibers; MNGIE = mitochondrial neurogastrointestinal encephalopathy."
]
]
},
"mk19_a_nr_t50":{
"id":"mk19_a_nr_t50",
"number":50,
"bookId":"nr",
"title":{
"__html":"Clinical Features of Myopathies"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"f74cdf",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 50. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t50"
}
]
},
"Clinical Features of Myopathies"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7962dd",
"class":"col hd l",
"children":[
"Clinical Features"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a44fd1",
"class":"col hd l",
"children":[
"Differential Diagnosis"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"19852c",
"class":"cell txt l",
"children":[
"Pain"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"89fba8",
"class":"cell txt l",
"children":[
"Metabolic, toxic, infectious, inflammatory, and mitochondrial myopathies"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f0144f",
"class":"cell txt l",
"children":[
"Stiffness"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7e7e82",
"class":"cell txt l",
"children":[
"Myotonic dystrophy, myotonic channelopathies, hyperkalemic periodic paralysis, hypothyroidism; differential diagnosis: stiff person syndrome"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c18e46",
"class":"cell txt l",
"children":[
"Rapid course"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5b3e8a",
"class":"cell txt l",
"children":[
"Inflammatory, toxic, autoimmune, and endocrine myopathies"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4fb569",
"class":"cell txt l",
"children":[
"Very slow course, plus or minus focal atrophy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"becb68",
"class":"cell txt l",
"children":[
"Muscular dystrophies, congenital myopathies, metabolic myopathies"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c6bc78",
"class":"cell txt l",
"children":[
"Fluctuating weakness"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7c40a6",
"class":"cell txt l",
"children":[
"Mitochondrial myopathy, myasthenia gravis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fa30e4",
"class":"cell txt l",
"children":[
"Myoglobinuria"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0f909e",
"class":"cell txt l",
"children":[
"Toxic and infectious myopathy, trauma, metabolic myopathies (CPT II deficiency, McArdle disease, central core myopathy)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"372602",
"class":"cell txt l",
"children":[
"Respiratory muscle involvement"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"01b2b8",
"class":"cell txt l",
"children":[
"Muscular dystrophies, inflammatory, mitochondrial, and metabolic myopathies (acid maltase deficiency, debrancher deficiency)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d9d162",
"class":"cell txt l",
"children":[
"Cardiomyopathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0eb195",
"class":"cell txt l",
"children":[
"Myotonic dystrophies, muscular dystrophies (Emery-Dreifuss, Becker), mitochondrial and toxic myopathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fdcc30",
"class":"cell txt l",
"children":[
"Cataract"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7636c3",
"class":"cell txt l",
"children":[
"Myotonic dystrophies, mitochondrial myopathy"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"CPT II deficiency = carnitine palmitoyltransferase II deficiency."
]
]
}
}
}